Newborn Screening for Galactosemia: A Review of 5 Years of Data and Audit of a Revised Reporting Approach
- 1 March 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 56 (3) , 437-444
Abstract
Background: Availability of the galactose-1-phosphate uridyltransferase (GALT) assay for newborn (NB) screening has improved identification of classic galactosemia. Previously defined critical cutoffs for total galactose (Gal), typically 1.110 mmol/L (20 mg/dL), are still in use in laboratories measuring total Gal for the diagnosis of nonclassic galactosemias. Urgent notification/referral to a treatment center follows, although few of the NBs will need treatment. Methods: We reviewed all NB galactosemia-screening results and their corresponding clinical outcomes over a 5-year period (first phase, 1.32 × 106 NBs) and then over a 2-year period (second phase, 274 960 NBs). Each NB was screened for Gal and GALT. When Gal was increased and/or GALT was deficient, testing for percentage galactose-1-phosphate and/or DNA testing for common GALT mutations were performed. Results: Of 209 reported positive results, 89% did not indicate GALT deficiency. These non–GALT-deficient results represented mostly clinically benign cases with a Gal threshold of ≥1.110 mmol/L (≥20 mg/dL). The positive predictive value of a GALT cutoff of ≤40 μmol/L was 83%. After a protocol change that redefined a critical result as a GALT value ≤40 μmol/L and/or a Gal value ≥1.665 mmol/L (≥30 mg/dL), results were monitored for an additional 2 years. The new protocol dramatically reduced the number of urgent calls/referrals and reduced the total number of referrals by nearly half. Conclusions: Use of a GALT cutoff of ≤40 μmol/L/L and a Gal cutoff of ≥1.665 mmol/L (≥30 mg/dL) for urgent notification/referral dramatically reduces false positives and unnecessary follow-up, thereby reducing the stress on healthcare resources.Keywords
This publication has 5 references indexed in Scilit:
- Duarte (DG) galactosemia: A pilot study of biochemical and neurodevelopmental assessment in children detected by newborn screeningMolecular Genetics and Metabolism, 2008
- Epimerase-Deficiency Galactosemia Is Not a Binary ConditionThe American Journal of Human Genetics, 2006
- Analysis of Common Mutations in the Galactose-1-Phosphate Uridyl Transferase GeneThe Journal of Molecular Diagnostics, 2003
- Molecular characterization of a unique patient with epimerase‐deficiency galactosaemiaJournal of Inherited Metabolic Disease, 1998
- Dual-channel continuous-flow system for determination of phenylalanine and galactose: application to newborn screening.Clinical Chemistry, 1984